Automated Segmentation Tool for Brain Infusions

PLoS ONE

Volumn 8, Issue 6, 2013, Pages

  Rosenbluth, Kathryn Hammond ^a   Gimenez, Francisco ^a   Kells, Adrian P ^a   Salegio, Ernesto A ^a   Mittermeyer, Gabriele M ^a   Modera, Kevin ^a   Kohal, Anmol ^a   Bankiewicz, Krystof S ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GADOLINIUM; CONTRAST MEDIUM; GADOTERIDOL; HETEROCYCLIC COMPOUND; ORGANOMETALLIC COMPOUND;

ARTICLE; AUTOANALYSIS; AUTOSEGMENTATION; COMPUTER PROGRAM; DIGITAL IMAGING AND COMMUNICATIONS IN MEDICINE; IMAGE ANALYSIS; INFUSION SYSTEM; MATHEMATICAL COMPUTING; NEUROIMAGING; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PICTURE ARCHIVING AND COMMUNICATION SYSTEM; PUTAMEN; RETROSPECTIVE STUDY; THALAMUS; VALIDATION PROCESS; ADMINISTRATION AND DOSAGE; ALGORITHM; ANIMAL; COMPUTER ASSISTED DIAGNOSIS; DEPENDOPARVOVIRUS; GENE THERAPY; GENE VECTOR; GENETICS; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; METABOLISM; OBSERVER VARIATION; PHARMACOKINETICS; PRIMATE;

PRIMATES;

ALGORITHMS; ANIMALS; CONTRAST MEDIA; DEPENDOVIRUS; GADOLINIUM; GENETIC THERAPY; GENETIC VECTORS; HETEROCYCLIC COMPOUNDS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; INFUSIONS, INTRAVENTRICULAR; MAGNETIC RESONANCE IMAGING; NEUROIMAGING; OBSERVER VARIATION; ORGANOMETALLIC COMPOUNDS; PRIMATES; PUTAMEN; SOFTWARE; THALAMUS;

EID: 84878761183     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0064452     Document Type: Article

References (37)

1. Bobo RH, Laske DW, Akbasak A, Morrison PF, Dedrick RL, et al. (1994) Convection-enhanced delivery of macromolecules in the brain. Proc Natl Acad Sci U S A 91: 2076-2080.
2. Richardson RM, Kells AP, Martin AJ, Larson PS, Starr PA, et al. (2011) Novel platform for MRI-guided convection-enhanced delivery of therapeutics: preclinical validation in nonhuman primate brain. Stereotact Funct Neurosurg 89: 141-151.
3. Krauze MT, Saito R, Noble C, Tamas M, Bringas J, et al. (2005) Reflux-free cannula for convection-enhanced high-speed delivery of therapeutic agents. J Neurosurg 103: 923-929.
4. Sampson JH, Raghavan R, Brady ML, Provenzale JM, Herndon JE, et al. (2007) Clinical utility of a patient-specific algorithm for simulating intracerebral drug infusions. Neuro-oncology 9: 343-353.
5. Rosenbluth KH, Eschermann JF, Mittermeyer G, Thomson R, Mittermeyer S, et al. (2012) Analysis of a simulation algorithm for direct brain drug delivery. Neuroimage 59: 2423-2429.
6. Lang AE, Gill S, Patel NK, Lozano A, Nutt JG, et al. (2006) Randomized controlled trial of intraputamenal glial cell line-derived neurotrophic factor infusion in Parkinson disease. Ann Neurol 59: 459-466.
7. Morrison PF, Lonser RR, Oldfield EH, (2007) Convective delivery of glial cell line-derived neurotrophic factor in the human putamen. J Neurosurg 107: 74-83.
8. Marks WJ, Stacy M (2009) A Phase I/II Trial Assessing the Safety and Efficacy of Bilateral Intraputaminal and Intranigral Administration of CERE-120 (Adeno-Associated Virus Serotype 2 [AAV2]-Neurturin [NTN]) in Subjects with Idiopathic Parkinson's Disease). Minutes of the National Institutes of Health Recombinant DNA Advisory Committee.
9. Valles F, Fiandaca MS, Eberling JL, Starr PA, Larson PS, et al. (2010) Qualitative imaging of adeno-associated virus serotype 2-human aromatic L-amino acid decarboxylase gene therapy in a phase I study for the treatment of Parkinson disease. Neurosurgery 67: 1377-1385.
10. Sampson JH, Archer G, Pedain C, Wembacher-Schroder E, Westphal M, et al. (2009) Poor drug distribution as a possible explanation for the results of the PRECISE trial. J Neurosurg.
11. Kunwar S, Prados MD, Chang SM, Berger MS, Lang FF, et al. (2007) Direct intracerebral delivery of cintredekin besudotox (IL13-PE38QQR) in recurrent malignant glioma: a report by the Cintredekin Besudotox Intraparenchymal Study Group. J Clin Oncol 25: 837-844.
12. Lidar Z, Mardor Y, Jonas T, Pfeffer R, Faibel M, et al. (2004) Convection-enhanced delivery of paclitaxel for the treatment of recurrent malignant glioma: a phase I/II clinical study. J Neurosurg 100: 472-479.
13. Dickinson PJ, LeCouteur RA, Higgins RJ, Bringas JR, Roberts B, et al. (2008) Canine model of convection-enhanced delivery of liposomes containing CPT-11 monitored with real-time magnetic resonance imaging: laboratory investigation. J Neurosurg 108: 989-998.
14. Yin D, Valles FE, Fiandaca MS, Bringas J, Gimenez F, et al. (2011) Optimal region of the putamen for image-guided convection-enhanced delivery of therapeutics in human and non-human primates. Neuroimage 54Suppl 1: S196-203.
15. Richardson RM, Gimenez F, Salegio EA, Su X, Bringas J, et al. (2011) T2 imaging in monitoring of intraparenchymal real-time convection-enhanced delivery. Neurosurgery 69: 154-163.
16. Lonser RR, Warren KE, Butman JA, Quezado Z, Robison RA, et al. (2007) Real-time image-guided direct convective perfusion of intrinsic brainstem lesions. Technical note. J Neurosurg 107: 190-197.
17. Titterington D, Smith A, Makov U (1985) Statistical Analysis of Finite Mixture Distributions: John Wiley & Sons.
18. Lei T, Sewchand W, (1992) Statistical approach to X-ray CT imaging and its applications in image analysis. II. A new stochastic model-based image segmentation technique for X-ray CT image. IEEE Trans Med Imaging 11: 62-69.
19. Liang Z, Macfall JR, Harrington DP, (1994) Parameter estimation and tissue segmentation from multispectral MR images. IEEE Trans Med Imaging 13: 441-449.
20. Pham DL, Xu C, Prince JL, (2000) Current methods in medical image segmentation. Annu Rev Biomed Eng 2: 315-337.
21. Su X, Kells AP, Huang EJ, Lee HS, Hadaczek P, et al. (2009) Safety evaluation of AAV2-GDNF gene transfer into the dopaminergic nigrostriatal pathway in aged and parkinsonian rhesus monkeys. Hum Gene Ther 20: 1627-1640.
22. Richardson RM, Kells AP, Rosenbluth KH, Salegio EA, Fiandaca MS, et al. (2011) Interventional MRI-guided putaminal delivery of AAV2-GDNF for a planned clinical trial in Parkinson's disease. Mol Ther 19: 1048-1057.
23. Sampson JH, Raghavan R, Provenzale JM, Croteau D, Reardon DA, et al. (2007) Induction of hyperintense signal on T2-weighted MR images correlates with infusion distribution from intracerebral convection-enhanced delivery of a tumor-targeted cytotoxin. AJR Am J Roentgenol 188: 703-709.
24. Dalrymple LS, Koepsell T, Sampson J, Louie T, Dominitz JA, et al. (2007) Hepatitis C virus infection and the prevalence of renal insufficiency. Clin J Am Soc Nephrol 2: 715-721.
25. Jagannathan J, Walbridge S, Butman JA, Oldfield EH, Lonser RR, (2008) Effect of ependymal and pial surfaces on convection-enhanced delivery. J Neurosurg 109: 547-552.
26. Sampson JH, Brady M, Raghavan R, Mehta AI, Friedman AH, et al. (2011) Colocalization of gadolinium-diethylene triamine pentaacetic Acid with high-molecular-weight molecules after intracerebral convection-enhanced delivery in humans. Neurosurgery 69: 668-676.
27. Nguyen TT, Pannu YS, Sung C, Dedrick RL, Walbridge S, et al. (2003) Convective distribution of macromolecules in the primate brain demonstrated using computerized tomography and magnetic resonance imaging. J Neurosurg 98: 584-590.
28. Murad GJ, Walbridge S, Morrison PF, Szerlip N, Butman JA, et al. (2007) Image-guided convection-enhanced delivery of gemcitabine to the brainstem. J Neurosurg 106: 351-356.
29. Saito R, Bringas JR, McKnight TR, Wendland MF, Mamot C, et al. (2004) Distribution of liposomes into brain and rat brain tumor models by convection-enhanced delivery monitored with magnetic resonance imaging. Cancer Res 64: 2572-2579.
30. San Sebastian W, Richardson RM, Kells AP, Lamarre C, Bringas J, et al. (2012) Safety and tolerability of magnetic resonance imaging-guided convection-enhanced delivery of AAV2-hAADC with a novel delivery platform in nonhuman primate striatum. Hum Gene Ther 23: 210-217.
31. Bankiewicz KS, Forsayeth J, Eberling JL, Sanchez-Pernaute R, Pivirotto P, et al. (2006) Long-term clinical improvement in MPTP-lesioned primates after gene therapy with AAV-hAADC. Mol Ther 14: 564-570.
32. Eberling JL, Jagust WJ, Christine CW, Starr P, Larson P, et al. (2008) Results from a phase I safety trial of hAADC gene therapy for Parkinson disease. Neurology 70: 1980-1983.
33. Ostertag D, Amundson KK, Lopez Espinoza F, Martin B, Buckley T, et al. (2012) Brain tumor eradication and prolonged survival from intratumoral conversion of 5-fluorocytosine to 5-fluorouracil using a nonlytic retroviral replicating vector. Neuro Oncol 14: 145-159.
34. Tai CK, Wang WJ, Chen TC, Kasahara N, (2005) Single-shot, multicycle suicide gene therapy by replication-competent retrovirus vectors achieves long-term survival benefit in experimental glioma. Mol Ther 12: 842-851.
35. Fiandaca MS, Berger MS, Bankiewicz KS, (2011) The use of convection-enhanced delivery with liposomal toxins in neurooncology. Toxins (Basel) 3: 369-397.
36. Noble CO, Krauze MT, Drummond DC, Yamashita Y, Saito R, et al. (2006) Novel nanoliposomal CPT-11 infused by convection-enhanced delivery in intracranial tumors: pharmacology and efficacy. Cancer Res 66: 2801-2806.
37. Krauze MT, Noble CO, Kawaguchi T, Drummond D, Kirpotin DB, et al. (2007) Convection-enhanced delivery of nanoliposomal CPT-11 (irinotecan) and PEGylated liposomal doxorubicin (Doxil) in rodent intracranial brain tumor xenografts. Neuro Oncol 9: 393-403.